HomeCompareFGBFX vs JNJ

FGBFX vs JNJ: Dividend Comparison 2026

FGBFX yields 103.08% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FGBFX wins by $4.39M in total portfolio value
10 years
FGBFX
FGBFX
● Live price
103.08%
Share price
$8.27
Annual div
$8.52
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.41M
Annual income
$1,517,845.36
Full FGBFX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — FGBFX vs JNJ

📍 FGBFX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFGBFXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FGBFX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FGBFX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FGBFX
Annual income on $10K today (after 15% tax)
$8,761.58/yr
After 10yr DRIP, annual income (after tax)
$1,290,168.56/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, FGBFX beats the other by $1,289,464.94/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FGBFX + JNJ for your $10,000?

FGBFX: 50%JNJ: 50%
100% JNJ50/50100% FGBFX
Portfolio after 10yr
$2.22M
Annual income
$759,336.57/yr
Blended yield
34.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

FGBFX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FGBFX buys
0
JNJ buys
0
No recent congressional trades found for FGBFX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFGBFXJNJ
Forward yield103.08%3.36%
Annual dividend / share$8.52$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$4.41M$20.0K
Annual income after 10y$1,517,845.36$827.78
Total dividends collected$3.95M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FGBFX vs JNJ ($10,000, DRIP)

YearFGBFX PortfolioFGBFX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$21,008$10,307.74$10,676$355.77+$10.3KFGBFX
2$42,716$20,237.60$11,407$389.39+$31.3KFGBFX
3$84,164$38,457.87$12,198$426.53+$72.0KFGBFX
4$160,872$70,817.03$13,056$467.62+$147.8KFGBFX
5$298,639$126,505.59$13,987$513.12+$284.7KFGBFX
6$539,022$219,478.02$14,998$563.56+$524.0KFGBFX
7$946,979$370,226.10$16,098$619.52+$930.9KFGBFX
8$1,621,147$607,879.48$17,295$681.69+$1.60MFGBFX
9$2,707,186$972,558.41$18,599$750.82+$2.69MFGBFX
10$4,414,535$1,517,845.36$20,022$827.78+$4.39MFGBFX

FGBFX vs JNJ: Complete Analysis 2026

FGBFXStock

The investment seeks a high level of current income. The fund invests in securities issued throughout the world, including securities of issuers located in emerging markets. It normally invests at least 80% of the fund&#39;s assets in debt securities of all types and repurchase agreements for those securities. The fund normally invests primarily in investment-grade debt securities.

Full FGBFX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this FGBFX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FGBFX vs SCHDFGBFX vs JEPIFGBFX vs OFGBFX vs KOFGBFX vs MAINFGBFX vs ABBVFGBFX vs MRKFGBFX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.